AgingResearch.News
AHA Scientific Sessions 2025 Abstract

GLP-1 Receptor Agonist Semaglutide Improves Hepatic Metabolism and Reverses Hepatic Steatosis Independent of Weight Loss in Cardiometabolic HFpEF

By Natalie Gehred, Tatiana Gromova, Mahmoud H. Elbatreek, Show 9 more authorsThomas M. Vondriska
Experiments in animalsInterventions
Paper

The paper

Natalie Gehred, Tatiana Gromova, Mahmoud H. Elbatreek, Show 9 more authorsThomas M. Vondriska

University of California, Los Angeles

AHA Scientific Sessions 2025 Abstract, 3 Nov 2025

Presented at AHA Scientific Sessions 2025, abstract 4366419

doi.org/10.1161/circ.152.suppl_3.4366419

Related